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Objectives: To develop effective and targeted interventions to improve care for patients with community-
acquired pneumonia (CAP), insight is needed into the factors that influence the quality of antibiotic use.
Therefore,wemeasured theperformanceofninequality indicators andstudieddeterminantsof variation in
the quality of antibiotic use.
Patients and methods: Data on 498 prospectively included patients with CAP from eight medium-sized
Dutch hospitals were extracted from the medical charts. Outcomes of nine indicators were calculated
using previously constructed algorithms. Multilevel logistic regression analysis was performed to
explain differences in performance rates at the patient, doctor and hospital level.
Results: Performance indicators were generally moderate. Markers of severe illness were found to be
positive predictors of timely administration of antibiotics (low oxygen saturation on admission OR 1.11;
95% CI: 1.04–1.19) and obtaining blood samples for culture (low sodium concentration on admission
OR 1.10; 95% CI: 1.03–1.16). Recent outpatient antibiotic therapy (OR 0.46; 95% CI: 0.26–0.80) and
presence of a hospital antibiotic committee (OR 0.27; 95% CI: 0.08–0.90) were negatively associated
with guideline-adherent empirical therapy. The main positive predictor of timely administration of
antibiotics (within 4 h) was antibiotic administration in the Emergency Department (ED) (OR 3.9; 95%
CI: 1.96–8.73).
Conclusions: We gained new insights into factors that determine quality of antibiotic prescription in
hospitals. Treatment in the ED, rather than in the ward, will result in earlier administration of antibiotics.
Guidelines should clarify preferred antibiotic management of patients who have received antibiotics prior
to admission. Hospital-based structures aimed at quality improvement, such as antibiotic committees, do
not necessarily lead to better adherence to national standards. Efforts should bemade to encourage these
committees to implement national guidelines at a local level.
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Introduction
Community acquired pneumonia (CAP) affects 3–5 adults per
thousand per year with a mortality of 7–14% in hospitalized
patients.1,2 Pneumonia-related deaths, expenditure and varia-
tion in hospital care have led to efforts to identify markers of
the quality of inpatient care. These so-called quality indicators
are defined as measurable elements of practice performance, for
which there is evidence or consensus that they can assess the
quality—and hence the change of quality—of care provided.3
Several process-of-care quality indicators have been proposed
for CAP.4–6 Some of these markers have proved to be associated
with improved clinical outcome4,7–13 or with a reduction in
healthcare cost;14–16 others may simply represent good clinical
practice.17,18
Performance levels of process markers in CAP vary consider-
ably between hospitals.19 Little is known about factors that
explain this variation. Performance for some indicators has
been associated with a variety of patient, physician and hospital
factors.20,21 However, no study has analysed possible determin-
ants of all three levels in one model. Similarly, only a small
selection of indicators was evaluated in these studies, although
the description of a wider range of process variables might better
reflect the quality of the whole process of care. Also, markers of
hospital and physician commitment to the quality of antibiotic
prescription (such as presence of automated feedback systems and
membership to an antibiotic committee) were not taken into
account.
We conducted a prospective study on nine indicators of
the quality of clinical antibiotic prescription in patients with
CAP and analysed the extent to which the variations in indicator
performance could be explained by differences between hosp-
itals, doctors and patients. Recognition of underlying factors
could contribute to the development of effective and targeted
interventions to improve the quality of care for patients with
pneumonia.
Patients and methods
Setting and population
Our study was conducted on baseline measurements of a clustered
randomized controlled trial to test a multifaceted implementation
strategy to improve the quality of antibiotic use in lower
respiratory tract infections (LRTI) in hospitals. For this purpose, all
eligible medium-sized hospitals in the south-east of the Netherlands
were asked to participate. Eight out of 14 available hospitals agreed
to take part. These hospitals represent inpatient care at secondary
care hospitals, because non-university teaching and non-teaching hos-
pitals were included. Patients with CAP were selected using formal
inclusion criteria: radiological evidence of an infiltrate on chest X-ray
and ‡2 out of 6 clinical criteria (cough, coloured sputum, temperature
>38.5C, abnormal chest auscultation, white blood cells >10 or <4 ·
109/L or positive blood or pleural fluid culture). We excluded
patients with underlying immunodeficiency (HIV infection, neut-
ropenia and/or treatment with immunomodulating drugs), patients
already on treatment with antibiotics for another infection at the
time of admission, patients who had recently been discharged from
hospital with LRTI (<30 days) or who had been transferred to another
hospital or ICU, and patients who had died within 24 h of admission
or had a very poor prognosis (life expectancy <2 weeks on
admission).
Variables and data collection
Four data levels were analysed: processes of care (dependent variables)
and patient, care provider and hospital characteristics (independent
variables).
Dependent variables
Using a formal procedure, described in our recent publication22
(flowchart in Appendix 1; available as Supplementary data at http://
www.jac.oxfordjournals.org), we formulated draft indicators of the
appropriate use of antibiotics for CAP based on (1) national guidelines,
edited by the Dutch Working Party on Antibiotic Policy (SWAB)23
and the National Society for Respiratory Physicians (NVALT),24
(2) international guidelines25–28 and (3) a systematic review of the
literature (Appendix 2; available as Supplementary data at http://
www.jac.oxfordjournals.org).5–8,19,20,29–36 To assess the evidence base
(grades A–D) of every indicator, a literature review was performed
(Appendices 3 and 4; available as Supplementary data at http://www.
jac.oxfordjournals.org). Grade A recommendations were considered
valid. In grade B–D recommendations, a panel of 11 experts performed
a consensus procedure on the indicators’ relevance for (i) patient out-
come, (ii) reducing antimicrobial resistance and (iii) cost-containment.
To test applicability in practice, feasibility, reliability, opportunity for
improvement and case-mix stability were determined (Appendix 1).
This resulted in a set of nine quality indicators (Table 1). After selec-
tion, these indicators were implemented: numerators and enumerators
were defined, including cut-off values and algorithms to calculate
outcome. All relevant data were collected from chart review.
Independent variables and data collection
Relevant patient characteristics included demographic data (age, sex),
comorbidity (cerebrovascular disease, congestive heart failure, neo-
plastic disease, liver disease, renal disease, chronic alcoholism, chronic
lung disease and diabetes), physical examination on admission (mental
status, temperature, pulse rate, respiratory rate and systolic blood
pressure), and initial laboratory and radiology results (presence of
pleural effusion, arterial pH, oxygen saturation, blood urea nitrogen,
sodium, glucose and C-reactive protein). These variables were used to
calculate the pneumonia severity index (PSI)37 for every patient. We
also recorded whether the patients had received treatment with an
antibiotic within 30 days before admission, had arrived at night or
during a weekend and whether a resident had been involved in the
admission procedure. Over a 6 month period, data collection was
performed by research assistants present (actually working) at the
departments: they screened all new admissions 2–3 times a week
and—once a new admission was detected—completed the case report
form from the day of admission to the day of dismissal: this allowed the
detection of important clinical data (e.g. timing of first administration
of antibiotic; timing of performance of cultures, etc.) while the patient
was still in the ward. Data were collected from admission sheets,
medical and nursing records, medication charts, and microbiology
and radiology reports. Research assistants received intensive training
andwere supervised at regular intervals by the study supervisor. Before
the start of the project, as well as while it was being conducted, data
collection was validated at regular intervals: double chart review was
performed by two independent researchers in 10% of patients at two
pilot hospitals. The percentage of agreement between these researchers
on indicator level, corrected for chance, was expressed in kappa coef-
ficients and ranged between 0.5 and 1 (moderate—good). After com-
pletion, data sheets were made anonymous and entered into a database
by two research assistants. Double data entry was performed in 2% of
the patient data sheets. In total, 36 entry errors were detected in the
complete set of 4510 items (0.8%). The two data entry assistants
had entered 275 differences from a sample of 58 data sheets; each
Schouten et al.
576
 at Institute of Social Studies on A
ugust 7, 2015
http://jac.oxfordjournals.org/
D
ow
nloaded from
 
contained 294 variables: 1.6% (275/17052). The regional research
ethics committee approved the study. As our data were collected as
part of a local quality improvement (QI) project, all local hospital
committees waived the need for a written informed consent from
patients. Nonetheless, measures were taken to protect patient privacy.
Care provider characteristics were collected from individual ques-
tionnaires completed by all the specialists at our study hospitals. These
included demographic data (age, sex), subspecialty, clinical experience
(years of professional experience since specialist registration and
number of patients with CAP treated per year) and membership of
an antibiotic control and/or quality of care committee.
Hospital characteristics were obtained from a survey on Dutch
secondary care hospitals38 and included hospital size, teaching status,
presence of educational strategies (e.g. local guidelines, continuous
medical education on antibiotic prescription for residents and special-
ists), audit and feedback (e.g. feedback systems on antibiotic therapy),
organisational strategies (e.g. presence of an antibiotic committee,
attendance of medical microbiologists and/or clinical pharmacists at
ward rounds), restrictive strategies (e.g. restricted list of antibiotics,
automatic stop order or antibiotic order form), quality of care policies
(e.g. QI projects on antibiotic use performed in past 5 years) and
factors of guideline availability and accessibility (e.g. the use of
national guidelines in the composition process of local antibiotic pol-
icies, publication of a pocket booklet with guidelines, presence of
computerized guidelines).
Analysis
Frequencies were calculated to evaluate adherence to nine quality
indicators for antibiotic use (Table 1). Descriptive statistics were
used to compare hospital characteristics of our study sample with
national data (t-test and c2 test). Dichotomous hospital variables
that contained fewer than two cases per category and patient variables
that contained fewer than 30 cases per category were excluded from
analysis. Table 2 presents most independent variables that were suit-
able for analysis. If a correlation was detected between two independ-
ent variables (correlation coefficient >0.4), only one variable was
tested (e.g. the blood glucose level or presence of diabetes). Single
relationships between adherence to quality indicators and all charac-
teristics were studied, using univariate analysis (cross tabulations, c2
test and Student’s t-test). Multilevel (hospital, professional, patient)
stepwise logistic regression analysis was performed to explain differ-
ences in adherence levels to process of care (dependent) variables.
Separate multivariate backwards stepwise logistic regression models
were constructed in which each evaluable process of care formed the
dependent outcome and all the patient, doctor and hospital character-
istics that had bivariate associations with P < 0.10 formed the inde-
pendent variables. A random coefficient model was composed using
three levels (patients, care providers and hospitals) with a Glimmix
procedure in SAS (SAS for Windows V8.2). For every indicator, the
percentage of variance that the determinants could explain, was cal-
culated. The explained variance was computed using a method based
on a thresholdmodel.39Multilevel analysis was only performed on data
from doctors who had treated six or more patients during the study
period.We considered the attending specialist to have been the primary
decision-maker. Odds ratios were calculated to describe associations
between determinants and quality indicators. An OR >1 means a pos-
itive association with the quality indicator. Two-sided P-levels of
<0.05 were considered to be statistically significant.
Results
Study population
Eight hospitals agreed to participate in our study. On several
characteristics, our sample was comparable to 59 other Dutch
Table 1. Performance levels of quality indicators for antibiotic use in CAP
Quality indicator
Adherence
(median, %)
Range
(eight hospitals, %)
Supporting
evidenceb
1. Timely initiation of antibiotic therapy
(within 4 h after presentation)
68 36–87 B
2. Empirical antibiotic regimen
according to national guidelines
45 5–59 B
3. Adapting dose and dose interval
of antibiotics to renal function
77 40–100 D
4. Switching from iv to oral therapy,
according to existing criteria and
when clinically stable
81 35–93 B
5. Changing broad-spectrum empirical
into pathogen-directed therapy
(streamlining therapy)
80 50–100 C
6. Stopping antibiotic therapy after
three consecutive days of defervescencea
11 2–32 D
7. Taking two sets of blood
samples for culture
57 48–67 B
8. Obtaining sputum samples
for Gram stain and culture
54 24–100 D
9. Urine antigen testing against
Legionella spp. upon clinical suspicion
84 67–100 B
aIndicator not included in multilevel analysis.
bGrades A–D including references: for comment see Appendices 3 and 4 (available as Supplementary data at http://www.
jac.oxfordjournals.org).
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secondary care hospitals (Table 2). Between September 2002 and
March 2003, 498 patients with CAP were admitted to the internal
and respiratory medicine wards at these eight hospitals. A total of
62 were excluded out of 498 eligible patients, due to neutropenia
(2), immunosuppressive therapy (38), admission to ICU, death or
transfer to another hospital within 24 h (12), another culture-proven
infection, already receiving antibiotics on admission (4), recent
admission to hospital for LRTI (11) and poor prognosis (2).
Table 2 outlines the characteristics of patients, professionals and
hospital settings. The doctors responsible for the management of
patients with CAP were predominantly male (84%), with a mean
age of 48 years (SD 8). About half were respiratory care specialists
(53%). In 59% of cases, residents had been involved in the
admission procedure. Mean patient age was 74 years (SD 15),
62% had one or more co-morbid disorders and 47% had a
PSI > 3 on admission.
Performance of process-of-care (dependent) variables
Table 1 shows the median performance of nine process-of-care
indicators. There was wide interhospital variation. Lowest
adherence (median of 11%) was found for discontinuing antibiotic
therapy when no fever was present for three consecutive days. This
variable was not entered into analysis becausemultilevel modelling
was impossible due to the small number of patients (with little
variation among hospitals) in the adherent group.
Table 3 shows the results of multilevel regression analysis
on a selection of indicators and the explained variance of the
determinants on indicator outcome.
Factors associated with timely antibiotic administration
Several patient and hospital characteristics were independently
associated with antibiotic administration within 4 h of admission.
In 83 out of the 372 evaluable patients (22.3%), the first dose of
antibiotics was administered in the Emergency Department (ED).
Administration of antibiotics in the ED was strongly associated
with antibiotic administration within 4 h (OR 3.9; 95% CI:
1.96–8.73). Another predictor of timely administration of anti-
biotics was low oxygen saturation on admission (OR 1.11; 95%
CI: 1.04–1.19).
Table 2. Descriptive statistics: patients, professionals and hospitals
Hospitals n = 8 n = 59a P Professionals n = 68 SD
Mean number of beds, n (SD) 524 (169) 491 (286) 0.74b Mean age, years 48 8
Teaching hospital, n (%) 4 (50) 27 (46) 0.82c Gender, % male 84
Antibiotic committee, n (%) 4 (50) 43 (73) 0.18c Mean years in practice 21 9
Local antibiotic guidelines, n (%) 8 (100) 56 (95) 0.51c Specialty professional, % 53
Use of national guidelines in composition 2 (25) 9 (15) 0.52c Respiratory care physician
process of local policies, n (%) 3 (38) 31 (53) 0.43c Clinical experience, 78
Routine feedback on pathogen-directed 6 (75) 29 (49) 0.17c % >25 CAP patients/year
therapy, n (%) 3 (38) 23 (39) 0.92c Member of local antibiotic 7
Quality improvement project committee, %
in past 5 years, n (%) Special task in quality 70
Pharmacist present at ward rounds improvement projects, %
discussing antibiotic prescription, n (%) Special task in guideline
composition, % 32
Patients n = 498 SD Patients n = 498 SD
Evaluable patients, n (%)
Excluded patients, n (%)
432 (88)
62 (12)
Sodium mean
(mmol/L)
137 4
Male sex, n (%) 251 (58) pH, median 7.44 0.6
Age, median in years
PSI score >3 (%)
74
47
15 Antibiotic therapy
within 30 days, n (%)
139 (32)
Co-morbidity scored ‡1 (%)
COPD, n (%)
62
194 (45)
Admitted at night
or weekend, n (%)
210 (49)
Chronic heart failure, n (%)
Diabetes mellitus, n (%)
154 (35)
154 (35)
Admission to
respiratory unit, n (%)
332 (77)
Oxygen saturation, % mean
Temperature, C mean
65 (15)
92.3
Resident involved in the
admission procedure, n (%)
230 (53)
Pulse (beats per min), mean 38.1
97 5
1.1
21
aData from 59 Dutch secondary care hospitals.38
bt-test.
cx2 test.
dSum score of eight items: malignancy, liver disease, chronic heart failure, stroke, renal failure, diabetes, alcohol abuse and chronic lung disease.
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Factors associated with guideline-adherent empirical
therapy
There was poor adherence to a national, multidisciplinary guideline
on empirical antibiotic therapy for CAP from the Dutch Working
Party on Antibiotic Policy (39%) and also to the most recent
guideline from the National Society for Respiratory Physicians
(37%). Predictors associated with guideline-adherent antibiotic
prescription included the presence of co-morbid chronic obstruct-
ive pulmonary disease (COPD) (OR 2.40; 95% CI: 1.40–4.08).
Patients who had been treated with antibiotics for respiratory
tract infection prior to admission (43%) were less likely to be
treated according to national guidelines (OR 0.46; 95% CI:
0.26–0.80). On a hospital level, adherence was poorest at hospitals
that had antibiotic committees (OR 0.27; 95% CI: 0.08–0.90).
Factors associated with adapting antibiotic therapy:
dosage reduction in the presence of decreased renal
function, switching and streamlining therapy
Adaptation of dose or dose interval according to renal function,
adherent to local guidelines, was performed considerably well
(77%) and was associated with a number of factors: more advanced
age of the patients (OR 0.55; 95% CI: 0.39–0.68), admission to a
Table 3. Multivariate predictors of performance levels of quality indicators and explained variancea
OR (95% CI) P
Timely initiation of antibiotic therapy (within 4 h)
low oxygen saturation on admission 1.11 (1.04–1.19)b 0.004
COPD 0.51 (0.27–0.96) 0.026
initiation of antibiotic therapy at the ED 3.9 (1.96–8.73) 0.001
explained variance (%) 31.3
Empirical antibiotics according to national guidelines
pleural effusion present on admission 0.27 (0.12–0.65) 0.004
COPD 2.40 (1.40–4.08) 0.002
recent antibiotic therapy in outpatient setting (<30 days) 0.46 (0.26–0.80) 0.007
presence of an antibiotic committee 0.27 (0.08–0.90) 0.034
explained variance (%) 14.4
Adapting dose of antibiotic to renal function
age (patient) 0.55 (0.39–0.68)c <0.0001
heart failure 0.52 (0.28–0.96) 0.038
admission to a respiratory care ward 5.13 (2.56–10.23) <0.0001
presence of an antibiotic committee 8.82 (1.03–75.88) 0.048
explained variance (%) 37.4
Switching from iv to oral therapy
elinical experience of treating physician (no. of years) 0.95 (0.92–0.99) 0.042
explained variance (%) 34.1
Streamlining therapy
presence of a clinical pharmacist at ward meetings 0.24 (0.08–0.72) 0.012
teaching hospital 4.14 (1.44–11.96) 0.010
explained variance (%) 27.9
Taking two blood samples for culture
temperature on admission (>37.5C or <36.0C) 7.75 (4.53–13.23) <0.0001
low sodium concentration on admission 1.10 (1.03–1.16)d 0.003
treating physician other than pulmonologist 2.82 (1.30–6.13) 0.009
explained variance (%) 27.6
Obtaining sputum samples for Gram stain and culture
male sex (patient) 2.15 (1.29–3.56) 0.003
COPD 1.95 (1.16–3.26) 0.012
recent antibiotic therapy in outpatient setting (<30 days) 2.16 (1.28–3.64) 0.004
admission to a respiratory care ward 2.35 (1.18–4.59) 0.017
explained variance (%) 13.9
aData are presented as OR (95% CI); indicator ‘Urine antigen testing for Legionella’ is not shown; an OR >1 means a positive
association with the outcome variable.
bOR per % decrease in oxygen saturation.
cOR per 10 years increase in age (per 1 year increase in age: OR 0.94; 95% CI: 0.91–0.96).
dOR per mmol/L decrease in sodium concentration.
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respiratory care unit (OR 5.13; 95% CI: 2.56–10.23) and the pres-
ence of a local antibiotic committee (OR 8.82; 95%CI: 1.03–75.9).
In 81% of the patients with CAP, who were receiving intraven-
ous (iv) antibiotics, the treating physician had made the correct
decision to switch, or not to switch, from iv to oral antibiotics,
based on generally accepted criteria. When iv–oral switch was
performed, it had been done in a timelymanner, but the right choice
of oral antibiotic formulation was made in only 64 of 181 evaluable
patients (35%). Overall, switching could have been performed
safely at a median of 1.3 days (SD 2.3) earlier. In 103 out of
432 evaluable patients (24%), results of blood, sputum or pleural
fluid cultures with susceptibility testing or serology for atypical
pathogens (IgM forMycoplasma pneumoniae and Legionella sero-
type 1 antigen in urine) were available and considered relevant. In
80 out of these 103 patients, the physicians had changed from
empirical therapy to narrow spectrum antibiotic therapy targeted
at the causative pathogen (78%). In 54 out of the 80 cases (68%)
this occurred within 2 days after results had been brought to their
attention. Few independent predictors were detected by multilevel
analyses on accurate therapy switching and streamlining. Younger
specialists (fewer years of clinical experience) showed better
therapy-switching behaviour (OR 0.95; 95% CI: 0.92–0.99)
while streamlining was performed better at teaching hospitals
(OR 4.14; 95% CI: 1.44–11.96). Attendance of a clinical pharma-
cist at ward rounds was inversely associated with correct stream-
lining of therapy (OR 0.24; 95% CI: 0.08–0.72).
Factors associated with the performance of diagnostic
procedures: sputum cultures, blood cultures and
Legionella urine antigen testing
In 272 out of the 385 patients (71%), a physician’s order to perform
a sputum culture and Gram stain had been recorded on the medical
or nursing chart. In 54% of the patients with CAP, a sputum sample
for culture had actually been obtained and sent for culture during
hospital stay, as witnessed by written microbiology reports. In 39%
(26 out of the 67 evaluable patients), these samples had been
obtained before the start of antibiotic therapy. Receiving antibiotic
therapy in the 30 days preceding admission and the presence of
co-morbid COPD predicted the performance of sputum culture.
Respiratory care physicians were more likely to perform sputum
cultures than other hospital physicians. Collecting blood
samples for culture (57%) was associated with elevated/reduced
temperature and low sodium level on admission. Respiratory care
physicians performed fewer blood cultures than the other treating
physicians.
Urine testing for Legionella spp. had been performed in only 56
out of the 371 (15%) evaluable patients. When clinical suspicion of
Legionella spp. infection was explicitly mentioned in the medical
records, urine antigen testing was performed in 84%. Performance
of urine antigen testing was associated with markers of severe
illness at presentation: high C-reactive protein, low serum sodium
concentration and presence of co-morbidity, e.g. COPD (data not
shown). No significant determinants were found for ‘performing a
urine antigen test upon clinical suspicion’.
Discussion
On the basis of our results, we conclude that there is ample room
for improvement on almost all the quality indicators: on the initi-
ation of treatment, re-evaluating or changing treatment and on
performance of diagnostic procedures. Several important associ-
ations were demonstrated between patient, professional and hos-
pital characteristics and measured processes of care for CAP.
Factors that influence timely antibiotic administration, timely
collection of blood samples for culture and adherence to an admis-
sion guideline have been reported before.20,21 We studied perform-
ance on a set of nine quality indicators, which enabled us to
describe not just initial management, but the entire process of
antibiotic use in CAP, from admission to discharge.
In line with previous reports,20 vital sign abnormalities that
reflect severe disease (e.g. low oxygen saturation and low serum
sodium concentration) were positively associated with timely anti-
biotic administration and collection of blood cultures. These results
suggest that quality performance is generally better in patients who
are more seriously ill. However, since guidelines do not distinguish
between patients by severity of fever or de-saturation, blood cul-
tures should be performed in patients with CAP even if there is no
fever, and antibiotics should be promptly administered even to
patients with normal oxygen saturation on admission. A strong
association was found between antibiotic administration at the
ED and administration within 4 h (OR 3.9). This may seem a
trivial finding, but it offers an opportunity for QI strategies: in
earlier studies, administration of antibiotics at the ED yielded
low performance scores and important variations between
hospitals.8,40,41
Choosing an antibiotic that was not in accordance with national
guidelines was strongly associated with a history of treatment with
antibiotics within 30 days before hospital admission. Unless pre-
vious antibiotic use was specifically mentioned in national guide-
lines for a small subgroup23 (patients with COPD who have
recently been treated with antibiotics) this variable was not integ-
rated into our algorithms. Performance on this indicator was prob-
ably underrated: deviation from national guidelines may have been
justified in a considerable number of these patients. Subgroup
analysis showed that in patients who had not received prior anti-
biotic treatment, guideline adherence was 50% compared with 30%
in those who had received previous treatment (c2 test; P < 0.05).
Prior antibiotic therapy is a major factor that influences adherence
to guidelines on empirical treatment when a patient with CAP is
admitted to hospital. Large retrospective studies on the effective-
ness of different empirical antibiotic regimens did not take this into
account.10–12,42 As an increasing number of patients are being
treated in outpatient settings with broad-spectrum antibiotics,43
clear recommendations are needed on what should be done if a
patient fails to improve during initial outpatient management.
Therefore, a transmural guideline should be formulated on man-
agement of CAP, which is currently lacking in the Netherlands.
The presence of a local antibiotic committee was also associated
with a lower likelihood of adherence to national guidelines on
empirical therapy. This finding may initially seem surprising: hos-
pital antibiotic committees are thought to play an important role in
the design and implementation of local practice guidelines on
antibiotic prescription. In the Netherlands, national guidelines
on treatment of CAP were distributed to antibiotic committees
in all hospitals. In addition, the guideline was published in the
Dutch Journal of Medicine.23 Thus, better adherence to antibiotic
policies would be expected at hospitals with a local antibiotic
committee. A possible explanation for this paradox is that the
hospitals with an antibiotic committee were more pro-active in
making tailor-made recommendations on antibiotic therapy in
selected patients, which may have led to increased deviation
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from national guideline recommendations. Also, these committees
may have been more up-to-date with the recent literature on empir-
ical treatment for CAP, regarding issues that have not yet been
incorporated into the national guidelines (dating from 1998).
Finally, national guidelines, even if they were adequately dissem-
inated, may have been insufficiently implemented at the local
hospital level: our recent survey at Dutch hospitals indeed showed
that only 19% had consulted national guidelines during the com-
position of local practice guidelines.38 A more generally accepted
prescription quality measure, ‘adapting of antibiotic dose to
decreased renal function’, was found to be positively associated
with the presence of a local antibiotic committee.
There was wide interhospital variation in the performance of
some of our quality indicators. Some hospital factors (e.g. the
presence of an antibiotic control committee, presence of a clinical
pharmacist at clinical rounds) were found to independently predict
performance levels, but our sample size was too small to detect
other potential hospital determinants of adherence. Independent
variables, such as the presence of local guidelines, a restricted
list of antibiotics, or the presence of a medical microbiologist at
ward rounds, were not evaluable due to skewed distribution of these
variables within our group of hospitals. However, no significant
differences in baseline characteristics were found between our
hospitals and 59 other Dutch general hospitals (Table 2). Despite
the small sample size, we therefore feel that our positive findings
are generally applicable.
Unfortunately, we were also unable to ascertain involvement of
a microbiologist or a clinical pharmacist at the individual patient
level, as data on their (routine) involvement was collected at hos-
pital level. More individualized data might have helped to study the
role of microbiologists and clinical pharmacists in depth.
Finally, our sample of hospitals was a convenience sample. This
may have introduced a bias, as our hospitals may have been more
willing to participate in QI projects. However, no differences
between our sample and the 59 other Dutch general hospitals
were found in baseline characteristics and measures that
would suggest a positive attitude towards quality of antibiotic
use (e.g. performance of a QI project on antibiotic use in the
past 5 years).
This study generates insight into factors that determine the
quality of antibiotic use in hospitals. To ensure antibiotic admin-
istration within 4 h, patients with CAP should receive their first
dose of antibiotics at the ED. National guidelines on empirical
therapy should clarify the preferred antibiotic management of
patients who have been treated with antibiotics prior to admission.
Hospital-based QI structures, such as antibiotic committees, do not
necessarily lead to better adherence to national standards. Efforts
should be made to encourage these committees to implement
national guidelines at a local level.
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